Consistent with gross finding on tumor weights, serpin treatment decreased proliferation of pancreatic cancer cells in vivo as measured by Ki67 staining (P ≤ 0.001 for Serp-1 and NSP treatments; Figures 3A–3D). This evidence concerns the gene MKI67 and familial pancreatic carcinoma.